Yes gettting reimbursement/funding for new tests in the institutional settings and other agencies has many hurdles. Getting regulatory approval is only the first step. A product will not "take off" until the specialised commitees which usually are stacked with conservative clinicians as well as the "bean counters" finally are convinced of the cost / benefits. Only rarely do products appear that get priority funding. It all takes time and a lot of evidence.
- Forums
- ASX - By Stock
- it aint so easy
Yes gettting reimbursement/funding for new tests in the...
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)